Seguir
Cristobal Belda Iniesta
Cristobal Belda Iniesta
Instituto de Salud Carlos III/ HM Hospitales/ CSIC UAM
Dirección de correo verificada de isciii.es - Página principal
Título
Citado por
Citado por
Año
Screening for epidermal growth factor receptor mutations in lung cancer
R Rosell, T Moran, C Queralt, R Porta, F Cardenal, C Camps, M Majem, ...
New England Journal of Medicine 361 (10), 958-967, 2009
29282009
PI3K/Akt signalling pathway and cancer
JÁF Vara, E Casado, J de Castro, P Cejas, C Belda-Iniesta, ...
Cancer treatment reviews 30 (2), 193-204, 2004
27532004
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE …
N Thatcher, FR Hirsch, AV Luft, A Szczesna, TE Ciuleanu, M Dediu, ...
The lancet oncology 16 (7), 763-774, 2015
5382015
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ...
The Lancet Oncology 19 (4), 521-536, 2018
5332018
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
AM Borobia, AJ Carcas, M Pérez-Olmeda, L Castaño, MJ Bertran, ...
The Lancet 398 (10295), 121-130, 2021
4132021
Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain)
P Cejas, E Casado, C Belda-Iniesta, J De Castro, E Espinosa, A Redondo, ...
Cancer Causes & Control 15, 707-719, 2004
2432004
Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis
A Isidoro, E Casado, A Redondo, P Acebo, E Espinosa, AM Alonso, ...
Carcinogenesis 26 (12), 2095-2104, 2005
2262005
DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients
N García-Romero, J Carrión-Navarro, S Esteban-Rubio, E Lázaro-Ibáñez, ...
Oncotarget 8 (1), 1416, 2017
2192017
Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design
G Castano-Vinyals, N Aragonés, B Pérez-Gómez, V Martín, J Llorca, ...
Gaceta sanitaria 29, 308-315, 2015
2042015
KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis
P Cejas, M Lopez-Gomez, C Aguayo, R Madero, J de Castro Carpeno, ...
PloS one 4 (12), e8199, 2009
1962009
Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study
AR de Molina, J Sarmentero-Estrada, C Belda-Iniesta, M Tarón, ...
The lancet oncology 8 (10), 889-897, 2007
1792007
Engineering iron oxide nanoparticles for clinical settings
AL Cortajarena, D Ortega, SM Ocampo, A Gonzalez-García, P Couleaud, ...
Nanobiomedicine 1, 2, 2014
1572014
IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer
I Ibanez de Caceres, M Cortes-Sempere, C Moratilla, R Machado-Pinilla, ...
Oncogene 29 (11), 1681-1690, 2010
1562010
Randomized, double-blind, placebo-controlled, multicenter phase II study of onartuzumab plus bevacizumab versus placebo plus bevacizumab in patients with recurrent glioblastoma …
T Cloughesy, G Finocchiaro, C Belda-Iniesta, L Recht, AA Brandes, ...
Journal of clinical oncology 35 (3), 343-351, 2017
1332017
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer
S Chattopadhyay, R Machado-Pinilla, C Manguan-García, ...
Oncogene 25 (23), 3335-3345, 2006
1152006
DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer
V Moncho-Amor, I Ibañez de Cáceres, E Bandres, B Martinez-Poveda, ...
Oncogene 30 (6), 668-678, 2011
1122011
Cardiac toxicity: old and new issues in anti-cancer drugs
M Sereno, A Brunello, A Chiappori, J Barriuso, E Casado, C Belda, ...
Clinical and Translational Oncology 10, 35-46, 2008
1022008
IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer
M Cortes-Sempere, MP De Miguel, O Pernia, C Rodriguez, ...
Oncogene 32 (10), 1274-1283, 2013
962013
Vesicle-mediated control of cell function: The role of extracellular matrix and microenvironment
G Rackov, N Garcia-Romero, S Esteban-Rubio, A Ayuso-Sacido
Frontiers in physiology 9, 381148, 2018
872018
Cancer stem cells and cisplatin‐resistant cells isolated from non‐small‐lung cancer cell lines constitute related cell populations
BD Lopez‐Ayllon, V Moncho‐Amor, A Abarrategi, II de Cáceres, ...
Cancer medicine 3 (5), 1099-1111, 2014
872014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20